ask="6.07"
ask_size="100"
average_daily_volume="1509750"
bid="5.92"
bid_size="500"
book_value="0.21"
change="-0.24"
change_from_200_day_moving_average="0.55"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-1.78"
change_From_52_week_low="3.22"
change_in_percent="-3.83%"
close="6.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.42"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.59"
ex_dividend_date="N/A"
float_shares="71327000"
high="6.26"
high_52_weeks="7.80"
last_trade_date="1/17/2017"
last_trade_price="6.02"
last_trade_size="39855"
last_trade_time="4:00pm"
low="5.90"
low_52_weeks="2.80"
market_capitalization="637.88M"
moving_average_200_day="5.47"
moving_average_50_day="5.94"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.22"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+10.01%"
percent_change_from_50_day_moving_average="+1.39%"
percent_change_from_52_week_high="-22.82%"
percent_change_from_52_week_low="+115.00%"
previous_close="6.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="30.10"
price_per_sales="23.49"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="16.17"
stock_exchange="NCM"
symbol="KERX"
volume="1954306"
weeks_range_52="2.80 - 7.80"
